Global Viral Vector Production Market Size, Share & Trends Analysis Report By Type, By Indication, By Application, By Regional Outlook and Forecast, 2023

List of Tables

The Global Viral Vector Production Market size is expected to reach $3.9 billion by 2030, rising at a market growth of 19.1% CAGR during the forecast period.

This has created a higher demand for viral vectors in producing these therapies. Regulatory agencies recognizing the potential of gene therapies and offering support, expedited review processes, and incentives have contributed to the growth of the gene therapy. Consequently, the Gene Therapy segment would generate approximately 65.6 share of the market by 2030. This positive regulatory environment has encouraged the development and production of viral vectors. Thus, the rise in demand and awareness for gene therapy has positively impacted the market by creating a growing and dynamic landscape.

Engineering viral vectors for reduced immunogenicity, improved targeting, and controlled gene expression contributes to developing vectors tailored for specific therapeutic applications. Developing next-generation viral vector platforms, such as synthetic and hybrid vectors, expands the toolbox for gene delivery. These platforms aim to overcome limitations associated with traditional vectors, offering improved safety profiles and increased efficiency in gene transfer. Therefore, these advancements collectively drive the expansion of the market. Moreover, A growing pipeline in gene therapy addresses a diverse range of therapeutic targets, including genetic disorders, rare diseases, neurodegenerative conditions, and certain types of cancer. This diversity broadens the application of viral vectors, leading to increased production needs. The expansion of clinical trials in gene therapy and viral vaccines, driven by a robust pipeline, necessitates large-scale production of viral vectors for investigational treatments. Due to the above aspects, the market is expected to grow significantly.

Furthermore, Viral vector platforms, particularly adenoviruses, had been instrumental in developing several COVID-19 vaccines. This surge in demand had led to an increased focus on optimizing viral vector production processes to meet the global need for large-scale vaccine manufacturing. The pandemic had prompted an unprecedented acceleration of research and development efforts in the biopharmaceutical sector. This emphasis on equitable distribution had implications for the manufacturing capacity and scalability of viral vector production, driving innovations in production processes to meet the demands of a global vaccination effort. Thus, COVID-19 had a positive impact on the market.

However, Viral vector production involves complex and intricate processes, including cell culture, transfection, purification, and quality control. The complexity of these processes contributes to increased production costs, particularly in terms of skilled labor, specialized equipment, and consumables. Also, the production of viral vectors often requires specialized facilities with controlled environments to ensure the integrity and safety of the final product. Due to the above factors, market growth will be hampered in the coming years.

By Type Analysis

By type, the market is classified into adenoviral vectors, lentiviral vectors, retroviral vectors, adeno-associated viral vectors, and others. In 2022, the adeno-associated viral vectors segment registered the highest revenue share in the market. Adeno-associated viral vectors (AAVs) typically induce a minimal immune response, allowing for repeated administration without significant immune reactions. This low immunogenicity is advantageous for long-term and repeated treatments. AAVs can establish stable and long-lasting gene expression in dividing and non-dividing cells. This property is crucial for sustained therapeutic effects and reduces the need for frequent vector administration. They can infect both dividing and non-dividing partitions, making them versatile for targeting various cell types, including neurons, muscle cells, and liver cells.

By Indication Analysis

On the basis of indication, the market is segmented into cancer, genetic disorders, infectious diseases, and others. The genetic disorders segment acquired a substantial revenue share in the market in 2022. Viral vectors deliver therapeutic genes into target cells in patients with genetic disorders. The viral vector works as a delivery vehicle, carrying the corrected or functional gene to the cells affected by the genetic abnormality. This approach aims to replace or supplement the defective gene, addressing the root cause of the genetic disorder. Genetic disorders caused by enzyme deficiencies, such as lysosomal storage disorders, can be targeted using viral vectors. Introducing functional genes encoding missing enzymes into affected cells can help restore enzymatic activity and alleviate the accumulation of substrates that lead to disease symptoms.

By Application Analysis

Based on application, the market is fragmented into gene therapy and vaccinology. In 2022, the gene therapy segment held the highest revenue share in the market. Gene therapy can be applied using in vivo or ex vivo approaches. In in vivo gene therapy, viral vectors are directly administered to the patient to target specific tissues or organs. Ex vivo gene therapy involves modifying cells outside the patient's body before reinfusing them. The preference of approach depends on the target tissue and the therapeutic strategy. The increasing number of clinical trials and regulatory approvals is evidence of the success of viral vector-based gene therapies. Positive outcomes in clinical studies contribute to validating and accepting gene therapy as a viable treatment option for genetic disorders.

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region covered a considerable revenue share in the market in 2022. In recent years, the Asia-Pacific region has witnessed substantial growth in the biotechnology and pharmaceutical sectors. This growth is propelled by increasing investment in research and development, expanding healthcare infrastructure, and increasing government support for the biotech industry. As a result, there is a growth in demand for viral vectors in the region to support the development and production of advanced therapies. In addition, the Asia-Pacific region has a high hindrance of cancer, genetic disorders, and infectious diseases. As a result, there is an increased focus on developing gene therapies and viral vector-based vaccines to address these healthcare challenges. The demand for viral vectors as essential tools in developing therapies drives the growth of the market.

Recent Strategies Deployed in the Market

Dec-2023: Oxford Biomedica plc has entered into an agreement with TSGH SAS to acquire ABL Europe SAS, a dedicated GMP CMO (Good Manufacturing Practice Contract Manufacturing Organization). Through this acquisition, Oxford Biomedica seeks to enhance its presence in the cell and gene therapy sector. Furthermore, this acquisition will not only increase Oxford Biomedica's capabilities in process and analytical development and early-stage manufacturing but also address the rising client demand for process development.
Oct-2023: Andelyn Biosciences, Inc. entered into partnership with Purespring Therapeutics Limited, a biotech company. Through this partnership, the companies aim to speed up the manufacturing of their gene therapies for the treatment of chronic renal diseases. Additionally, it empowers Purespring to quicken the clinical development of its gene therapy program focused on chronic kidney diseases.
May-2023: Oxford Biomedica plc, a Contract Development and Manufacturing Organization (CDMO) specializing in high-quality and innovative viral vectors, has launched its fourth-generation lentiviral vector delivery system, TetraVectaTM. This technology from Oxford Biomedica enhances the quality, potency, and packaging capacity of lentiviral vectors. It also integrates new and improved safety features, further enriching the company's client offerings and reinforcing its position as a leader in the LentiVector platform.
Mar-2023: Charles River Laboratories International, Inc. unveiled its ready-made pHelper offering. Through this product, the company aims to ensure a stable supply and simplify adeno-associated virus (AAV)-based gene therapy programs from the initial stages of discovery to commercial manufacturing. Furthermore, the product is readily accessible in Research Grade (RG), High Quality (HQ), and Good Manufacturing Practice (GMP)-grade.
Oct-2022: Andelyn Biosciences, Inc. has broadened its manufacturing capacities by inaugurating a new GMP clinical and commercial manufacturing facility. This facility is intended to enhance the company's ability to produce and advance cell and gene therapy (CGT). Moreover, it will facilitate viral vector production through different methods, such as adherent, iCELLis, and suspension platforms.
Aug-2022: Thermo Fisher Scientific, Inc. has enhanced its capabilities in cell and gene therapy by inaugurating a new viral vector manufacturing facility in Plainville, Mass. This expansion includes the support for the development, testing, and production of viral vectors-essential components in the process of developing and bringing gene therapies to market.

List of Key Companies Profiled

Andelyn Biosciences, Inc.
Charles River Laboratories International, Inc.
Danaher Corporation
FinVector Oy (Ferring Ventures S/A)
Thermo Fisher Scientific, Inc.
Novartis AG
Takara Bio Inc. (Takara Holdings Inc.)
Avid Bioservices, Inc.
Oxford Biomedica plc
Lonza Group Ltd.

Global Viral Vector Production Market Report Segmentation

By Type

Adeno-Associated Viral Vectors
Lentiviral Vectors
Adenoviral Vectors
Retroviral Vectors
Others

By Indication

Cancer
Genetic Disorders
Infectious Diseases
Others

By Application

Gene Therapy
Vaccinology

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Viral Vector Production Market, by Type
- 1.4.2 Global Viral Vector Production Market, by Indication
- 1.4.3 Global Viral Vector Production Market, by Application
- 1.4.4 Global Viral Vector Production Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter's Five Forces Analysis

Chapter 4. Strategies Deployed in Viral Vector Production Market

Chapter 5. Global Viral Vector Production Market, by Type

5.1 Global Adeno-Associated Viral Vectors Market, by Region
5.2 Global Lentiviral Vectors Market, by Region
5.3 Global Adenoviral Vectors Market, by Region
5.4 Global Retroviral Vectors Market, by Region
5.5 Global Others Market, by Region

Chapter 6. Global Viral Vector Production Market, by Indication

6.1 Global Cancer Market, by Region
6.2 Global Genetic Disorders Market, by Region
6.3 Global Infectious Diseases Market, by Region
6.4 Global Others Market, by Region

Chapter 7. Global Viral Vector Production Market, by Application

7.1 Global Gene Therapy Market, by Region
7.2 Global Vaccinology Market, by Region

Chapter 8. Global Viral Vector Production Market, by Region

8.1 North America Viral Vector Production Market
- 8.1.1 North America Viral Vector Production Market, by Type
  - 8.1.1.1 North America Adeno-Associated Viral Vectors Market, by Country
  - 8.1.1.2 North America Lentiviral Vectors Market, by Country
  - 8.1.1.3 North America Adenoviral Vectors Market, by Country
  - 8.1.1.4 North America Retroviral Vectors Market, by Country
  - 8.1.1.5 North America Others Market, by Country
- 8.1.2 North America Viral Vector Production Market, by Indication
  - 8.1.2.1 North America Cancer Market, by Country
  - 8.1.2.2 North America Genetic Disorders Market, by Country
  - 8.1.2.3 North America Infectious Diseases Market, by Country
  - 8.1.2.4 North America Others Market, by Country
- 8.1.3 North America Viral Vector Production Market, by Application
  - 8.1.3.1 North America Gene Therapy Market, by Country
  - 8.1.3.2 North America Vaccinology Market, by Country
- 8.1.4 North America Viral Vector Production Market, by Country
  - 8.1.4.1 US Viral Vector Production Market
    - 8.1.4.1.1 US Viral Vector Production Market, by Type
    - 8.1.4.1.2 US Viral Vector Production Market, by Indication
    - 8.1.4.1.3 US Viral Vector Production Market, by Application
  - 8.1.4.2 Canada Viral Vector Production Market
    - 8.1.4.2.1 Canada Viral Vector Production Market, by Type
    - 8.1.4.2.2 Canada Viral Vector Production Market, by Indication
    - 8.1.4.2.3 Canada Viral Vector Production Market, by Application
  - 8.1.4.3 Mexico Viral Vector Production Market
    - 8.1.4.3.1 Mexico Viral Vector Production Market, by Type
    - 8.1.4.3.2 Mexico Viral Vector Production Market, by Indication
    - 8.1.4.3.3 Mexico Viral Vector Production Market, by Application
  - 8.1.4.4 Rest of North America Viral Vector Production Market
    - 8.1.4.4.1 Rest of North America Viral Vector Production Market, by Type
    - 8.1.4.4.2 Rest of North America Viral Vector Production Market, by Indication
    - 8.1.4.4.3 Rest of North America Viral Vector Production Market, by Application
8.2 Europe Viral Vector Production Market
- 8.2.1 Europe Viral Vector Production Market, by Type
  - 8.2.1.1 Europe Adeno-Associated Viral Vectors Market, by Country
  - 8.2.1.2 Europe Lentiviral Vectors Market, by Country
  - 8.2.1.3 Europe Adenoviral Vectors Market, by Country
  - 8.2.1.4 Europe Retroviral Vectors Market, by Country
  - 8.2.1.5 Europe Others Market, by Country
- 8.2.2 Europe Viral Vector Production Market, by Indication
  - 8.2.2.1 Europe Cancer Market, by Country
  - 8.2.2.2 Europe Genetic Disorders Market, by Country
  - 8.2.2.3 Europe Infectious Diseases Market, by Country
  - 8.2.2.4 Europe Others Market, by Country
- 8.2.3 Europe Viral Vector Production Market, by Application
  - 8.2.3.1 Europe Gene Therapy Market, by Country
  - 8.2.3.2 Europe Vaccinology Market, by Country
- 8.2.4 Europe Viral Vector Production Market, by Country
  - 8.2.4.1 Germany Viral Vector Production Market
    - 8.2.4.1.1 Germany Viral Vector Production Market, by Type
    - 8.2.4.1.2 Germany Viral Vector Production Market, by Indication
    - 8.2.4.1.3 Germany Viral Vector Production Market, by Application
  - 8.2.4.2 UK Viral Vector Production Market
    - 8.2.4.2.1 UK Viral Vector Production Market, by Type
    - 8.2.4.2.2 UK Viral Vector Production Market, by Indication
    - 8.2.4.2.3 UK Viral Vector Production Market, by Application
  - 8.2.4.3 France Viral Vector Production Market
    - 8.2.4.3.1 France Viral Vector Production Market, by Type
    - 8.2.4.3.2 France Viral Vector Production Market, by Indication
    - 8.2.4.3.3 France Viral Vector Production Market, by Application
  - 8.2.4.4 Russia Viral Vector Production Market
    - 8.2.4.4.1 Russia Viral Vector Production Market, by Type
    - 8.2.4.4.2 Russia Viral Vector Production Market, by Indication
    - 8.2.4.4.3 Russia Viral Vector Production Market, by Application
  - 8.2.4.5 Spain Viral Vector Production Market
    - 8.2.4.5.1 Spain Viral Vector Production Market, by Type
    - 8.2.4.5.2 Spain Viral Vector Production Market, by Indication
    - 8.2.4.5.3 Spain Viral Vector Production Market, by Application
  - 8.2.4.6 Italy Viral Vector Production Market
    - 8.2.4.6.1 Italy Viral Vector Production Market, by Type
    - 8.2.4.6.2 Italy Viral Vector Production Market, by Indication
    - 8.2.4.6.3 Italy Viral Vector Production Market, by Application
  - 8.2.4.7 Rest of Europe Viral Vector Production Market
    - 8.2.4.7.1 Rest of Europe Viral Vector Production Market, by Type
    - 8.2.4.7.2 Rest of Europe Viral Vector Production Market, by Indication
    - 8.2.4.7.3 Rest of Europe Viral Vector Production Market, by Application
8.3 Asia Pacific Viral Vector Production Market
- 8.3.1 Asia Pacific Viral Vector Production Market, by Type
  - 8.3.1.1 Asia Pacific Adeno-Associated Viral Vectors Market, by Country
  - 8.3.1.2 Asia Pacific Lentiviral Vectors Market, by Country
  - 8.3.1.3 Asia Pacific Adenoviral Vectors Market, by Country
  - 8.3.1.4 Asia Pacific Retroviral Vectors Market, by Country
  - 8.3.1.5 Asia Pacific Others Market, by Country
- 8.3.2 Asia Pacific Viral Vector Production Market, by Indication
  - 8.3.2.1 Asia Pacific Cancer Market, by Country
  - 8.3.2.2 Asia Pacific Genetic Disorders Market, by Country
  - 8.3.2.3 Asia Pacific Infectious Diseases Market, by Country
  - 8.3.2.4 Asia Pacific Others Market, by Country
- 8.3.3 Asia Pacific Viral Vector Production Market, by Application
  - 8.3.3.1 Asia Pacific Gene Therapy Market, by Country
  - 8.3.3.2 Asia Pacific Vaccinology Market, by Country
- 8.3.4 Asia Pacific Viral Vector Production Market, by Country
  - 8.3.4.1 China Viral Vector Production Market
    - 8.3.4.1.1 China Viral Vector Production Market, by Type
    - 8.3.4.1.2 China Viral Vector Production Market, by Indication
    - 8.3.4.1.3 China Viral Vector Production Market, by Application
  - 8.3.4.2 Japan Viral Vector Production Market
    - 8.3.4.2.1 Japan Viral Vector Production Market, by Type
    - 8.3.4.2.2 Japan Viral Vector Production Market, by Indication
    - 8.3.4.2.3 Japan Viral Vector Production Market, by Application
  - 8.3.4.3 India Viral Vector Production Market
    - 8.3.4.3.1 India Viral Vector Production Market, by Type
    - 8.3.4.3.2 India Viral Vector Production Market, by Indication
    - 8.3.4.3.3 India Viral Vector Production Market, by Application
  - 8.3.4.4 South Korea Viral Vector Production Market
    - 8.3.4.4.1 South Korea Viral Vector Production Market, by Type
    - 8.3.4.4.2 South Korea Viral Vector Production Market, by Indication
    - 8.3.4.4.3 South Korea Viral Vector Production Market, by Application
  - 8.3.4.5 Singapore Viral Vector Production Market
    - 8.3.4.5.1 Singapore Viral Vector Production Market, by Type
    - 8.3.4.5.2 Singapore Viral Vector Production Market, by Indication
    - 8.3.4.5.3 Singapore Viral Vector Production Market, by Application
  - 8.3.4.6 Malaysia Viral Vector Production Market
    - 8.3.4.6.1 Malaysia Viral Vector Production Market, by Type
    - 8.3.4.6.2 Malaysia Viral Vector Production Market, by Indication
    - 8.3.4.6.3 Malaysia Viral Vector Production Market, by Application
  - 8.3.4.7 Rest of Asia Pacific Viral Vector Production Market
    - 8.3.4.7.1 Rest of Asia Pacific Viral Vector Production Market, by Type
    - 8.3.4.7.2 Rest of Asia Pacific Viral Vector Production Market, by Indication
    - 8.3.4.7.3 Rest of Asia Pacific Viral Vector Production Market, by Application
8.4 LAMEA Viral Vector Production Market
- 8.4.1 LAMEA Viral Vector Production Market, by Type
  - 8.4.1.1 LAMEA Adeno-Associated Viral Vectors Market, by Country
  - 8.4.1.2 LAMEA Lentiviral Vectors Market, by Country
  - 8.4.1.3 LAMEA Adenoviral Vectors Market, by Country
  - 8.4.1.4 LAMEA Retroviral Vectors Market, by Country
  - 8.4.1.5 LAMEA Others Market, by Country
- 8.4.2 LAMEA Viral Vector Production Market, by Indication
  - 8.4.2.1 LAMEA Cancer Market, by Country
  - 8.4.2.2 LAMEA Genetic Disorders Market, by Country
  - 8.4.2.3 LAMEA Infectious Diseases Market, by Country
  - 8.4.2.4 LAMEA Others Market, by Country
- 8.4.3 LAMEA Viral Vector Production Market, by Application
  - 8.4.3.1 LAMEA Gene Therapy Market, by Country
  - 8.4.3.2 LAMEA Vaccinology Market, by Country
- 8.4.4 LAMEA Viral Vector Production Market, by Country
  - 8.4.4.1 Brazil Viral Vector Production Market
    - 8.4.4.1.1 Brazil Viral Vector Production Market, by Type
    - 8.4.4.1.2 Brazil Viral Vector Production Market, by Indication
    - 8.4.4.1.3 Brazil Viral Vector Production Market, by Application
  - 8.4.4.2 Argentina Viral Vector Production Market
    - 8.4.4.2.1 Argentina Viral Vector Production Market, by Type
    - 8.4.4.2.2 Argentina Viral Vector Production Market, by Indication
    - 8.4.4.2.3 Argentina Viral Vector Production Market, by Application
  - 8.4.4.3 UAE Viral Vector Production Market
    - 8.4.4.3.1 UAE Viral Vector Production Market, by Type
    - 8.4.4.3.2 UAE Viral Vector Production Market, by Indication
    - 8.4.4.3.3 UAE Viral Vector Production Market, by Application
  - 8.4.4.4 Saudi Arabia Viral Vector Production Market
    - 8.4.4.4.1 Saudi Arabia Viral Vector Production Market, by Type
    - 8.4.4.4.2 Saudi Arabia Viral Vector Production Market, by Indication
    - 8.4.4.4.3 Saudi Arabia Viral Vector Production Market, by Application
  - 8.4.4.5 South Africa Viral Vector Production Market
    - 8.4.4.5.1 South Africa Viral Vector Production Market, by Type
    - 8.4.4.5.2 South Africa Viral Vector Production Market, by Indication
    - 8.4.4.5.3 South Africa Viral Vector Production Market, by Application
  - 8.4.4.6 Nigeria Viral Vector Production Market
    - 8.4.4.6.1 Nigeria Viral Vector Production Market, by Type
    - 8.4.4.6.2 Nigeria Viral Vector Production Market, by Indication
    - 8.4.4.6.3 Nigeria Viral Vector Production Market, by Application
  - 8.4.4.7 Rest of LAMEA Viral Vector Production Market
    - 8.4.4.7.1 Rest of LAMEA Viral Vector Production Market, by Type
    - 8.4.4.7.2 Rest of LAMEA Viral Vector Production Market, by Indication
    - 8.4.4.7.3 Rest of LAMEA Viral Vector Production Market, by Application

Chapter 9. Company Profiles

9.1 Andelyn Biosciences, Inc.
- 9.1.1 Company Overview
- 9.1.2 Recent strategies and developments:
  - 9.1.2.1 Partnerships, Collaborations, and Agreements:
  - 9.1.2.2 Geographical Expansions:
9.2 Charles River Laboratories International, Inc.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Recent strategies and developments:
  - 9.2.4.1 Product Launches and Product Expansions:
  - 9.2.4.2 Acquisition and Mergers:
  - 9.2.4.3 Geographical Expansions:
- 9.2.5 SWOT Analysis
9.3 Danaher Corporation
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 SWOT Analysis
9.4 FinVector Oy (Ferring Ventures S/A)
- 9.4.1 Company Overview
9.5 Thermo Fisher Scientific, Inc.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 Recent strategies and developments:
  - 9.5.5.1 Acquisition and Mergers:
  - 9.5.5.2 Geographical Expansions:
- 9.5.6 SWOT Analysis
9.6 Novartis AG
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 SWOT Analysis
9.7 Takara Bio Inc. (Takara Holdings Inc.)
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
9.8 Avid Bioservices, Inc.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Recent strategies and developments:
  - 9.8.3.1 Geographical Expansions:
9.9 Oxford Biomedica plc
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expenses
- 9.9.5 Recent strategies and developments:
  - 9.9.5.1 Partnerships, Collaborations, and Agreements:
  - 9.9.5.2 Product Launches and Product Expansions:
9.10. Lonza Group Ltd.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 SWOT Analysis

Chapter 10. Winning Imperatives of Viral Vector Production Market

LIST OF TABLES

TABLE 1 Global Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 2 Global Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 3 Global Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 4 Global Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 5 Global Adeno-Associated Viral Vectors Market, by Region, 2019 - 2022, USD Million
TABLE 6 Global Adeno-Associated Viral Vectors Market, by Region, 2023 - 2030, USD Million
TABLE 7 Global Lentiviral Vectors Market, by Region, 2019 - 2022, USD Million
TABLE 8 Global Lentiviral Vectors Market, by Region, 2023 - 2030, USD Million
TABLE 9 Global Adenoviral Vectors Market, by Region, 2019 - 2022, USD Million
TABLE 10 Global Adenoviral Vectors Market, by Region, 2023 - 2030, USD Million
TABLE 11 Global Retroviral Vectors Market, by Region, 2019 - 2022, USD Million
TABLE 12 Global Retroviral Vectors Market, by Region, 2023 - 2030, USD Million
TABLE 13 Global Others Market, by Region, 2019 - 2022, USD Million
TABLE 14 Global Others Market, by Region, 2023 - 2030, USD Million
TABLE 15 Global Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 16 Global Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 17 Global Cancer Market, by Region, 2019 - 2022, USD Million
TABLE 18 Global Cancer Market, by Region, 2023 - 2030, USD Million
TABLE 19 Global Genetic Disorders Market, by Region, 2019 - 2022, USD Million
TABLE 20 Global Genetic Disorders Market, by Region, 2023 - 2030, USD Million
TABLE 21 Global Infectious Diseases Market, by Region, 2019 - 2022, USD Million
TABLE 22 Global Infectious Diseases Market, by Region, 2023 - 2030, USD Million
TABLE 23 Global Others Market, by Region, 2019 - 2022, USD Million
TABLE 24 Global Others Market, by Region, 2023 - 2030, USD Million
TABLE 25 Global Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 26 Global Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 27 Global Gene Therapy Market, by Region, 2019 - 2022, USD Million
TABLE 28 Global Gene Therapy Market, by Region, 2023 - 2030, USD Million
TABLE 29 Global Vaccinology Market, by Region, 2019 - 2022, USD Million
TABLE 30 Global Vaccinology Market, by Region, 2023 - 2030, USD Million
TABLE 31 Global Viral Vector Production Market, by Region, 2019 - 2022, USD Million
TABLE 32 Global Viral Vector Production Market, by Region, 2023 - 2030, USD Million
TABLE 33 North America Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 34 North America Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 35 North America Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 36 North America Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 37 North America Adeno-Associated Viral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 38 North America Adeno-Associated Viral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 39 North America Lentiviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 40 North America Lentiviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 41 North America Adenoviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 42 North America Adenoviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 43 North America Retroviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 44 North America Retroviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 45 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 46 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 47 North America Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 48 North America Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 49 North America Cancer Market, by Country, 2019 - 2022, USD Million
TABLE 50 North America Cancer Market, by Country, 2023 - 2030, USD Million
TABLE 51 North America Genetic Disorders Market, by Country, 2019 - 2022, USD Million
TABLE 52 North America Genetic Disorders Market, by Country, 2023 - 2030, USD Million
TABLE 53 North America Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 54 North America Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 55 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 56 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 57 North America Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 58 North America Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 59 North America Gene Therapy Market, by Country, 2019 - 2022, USD Million
TABLE 60 North America Gene Therapy Market, by Country, 2023 - 2030, USD Million
TABLE 61 North America Vaccinology Market, by Country, 2019 - 2022, USD Million
TABLE 62 North America Vaccinology Market, by Country, 2023 - 2030, USD Million
TABLE 63 North America Viral Vector Production Market, by Country, 2019 - 2022, USD Million
TABLE 64 North America Viral Vector Production Market, by Country, 2023 - 2030, USD Million
TABLE 65 US Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 66 US Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 67 US Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 68 US Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 69 US Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 70 US Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 71 US Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 72 US Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 73 Canada Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 74 Canada Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 75 Canada Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 76 Canada Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 77 Canada Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 78 Canada Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 79 Canada Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 80 Canada Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 81 Mexico Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 82 Mexico Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 83 Mexico Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 84 Mexico Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 85 Mexico Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 86 Mexico Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 87 Mexico Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 88 Mexico Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 89 Rest of North America Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 90 Rest of North America Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 91 Rest of North America Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 92 Rest of North America Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 93 Rest of North America Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 94 Rest of North America Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 95 Rest of North America Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 96 Rest of North America Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 97 Europe Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 98 Europe Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 99 Europe Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 100 Europe Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 101 Europe Adeno-Associated Viral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 102 Europe Adeno-Associated Viral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 103 Europe Lentiviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 104 Europe Lentiviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 105 Europe Adenoviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 106 Europe Adenoviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 107 Europe Retroviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 108 Europe Retroviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 109 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 110 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 111 Europe Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 112 Europe Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 113 Europe Cancer Market, by Country, 2019 - 2022, USD Million
TABLE 114 Europe Cancer Market, by Country, 2023 - 2030, USD Million
TABLE 115 Europe Genetic Disorders Market, by Country, 2019 - 2022, USD Million
TABLE 116 Europe Genetic Disorders Market, by Country, 2023 - 2030, USD Million
TABLE 117 Europe Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 118 Europe Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 119 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 120 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 121 Europe Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 122 Europe Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 123 Europe Gene Therapy Market, by Country, 2019 - 2022, USD Million
TABLE 124 Europe Gene Therapy Market, by Country, 2023 - 2030, USD Million
TABLE 125 Europe Vaccinology Market, by Country, 2019 - 2022, USD Million
TABLE 126 Europe Vaccinology Market, by Country, 2023 - 2030, USD Million
TABLE 127 Europe Viral Vector Production Market, by Country, 2019 - 2022, USD Million
TABLE 128 Europe Viral Vector Production Market, by Country, 2023 - 2030, USD Million
TABLE 129 Germany Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 130 Germany Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 131 Germany Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 132 Germany Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 133 Germany Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 134 Germany Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 135 Germany Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 136 Germany Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 137 UK Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 138 UK Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 139 UK Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 140 UK Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 141 UK Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 142 UK Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 143 UK Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 144 UK Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 145 France Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 146 France Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 147 France Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 148 France Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 149 France Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 150 France Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 151 France Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 152 France Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 153 Russia Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 154 Russia Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 155 Russia Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 156 Russia Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 157 Russia Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 158 Russia Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 159 Russia Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 160 Russia Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 161 Spain Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 162 Spain Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 163 Spain Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 164 Spain Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 165 Spain Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 166 Spain Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 167 Spain Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 168 Spain Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 169 Italy Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 170 Italy Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 171 Italy Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 172 Italy Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 173 Italy Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 174 Italy Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 175 Italy Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 176 Italy Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 177 Rest of Europe Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 178 Rest of Europe Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 179 Rest of Europe Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 180 Rest of Europe Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 181 Rest of Europe Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 182 Rest of Europe Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 183 Rest of Europe Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 184 Rest of Europe Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 185 Asia Pacific Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 186 Asia Pacific Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 187 Asia Pacific Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 188 Asia Pacific Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 189 Asia Pacific Adeno-Associated Viral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 190 Asia Pacific Adeno-Associated Viral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 191 Asia Pacific Lentiviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 192 Asia Pacific Lentiviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 193 Asia Pacific Adenoviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 194 Asia Pacific Adenoviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 195 Asia Pacific Retroviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 196 Asia Pacific Retroviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 197 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
TABLE 198 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
TABLE 199 Asia Pacific Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 200 Asia Pacific Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 201 Asia Pacific Cancer Market, by Country, 2019 - 2022, USD Million
TABLE 202 Asia Pacific Cancer Market, by Country, 2023 - 2030, USD Million
TABLE 203 Asia Pacific Genetic Disorders Market, by Country, 2019 - 2022, USD Million
TABLE 204 Asia Pacific Genetic Disorders Market, by Country, 2023 - 2030, USD Million
TABLE 205 Asia Pacific Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 206 Asia Pacific Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 207 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
TABLE 208 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
TABLE 209 Asia Pacific Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 210 Asia Pacific Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 211 Asia Pacific Gene Therapy Market, by Country, 2019 - 2022, USD Million
TABLE 212 Asia Pacific Gene Therapy Market, by Country, 2023 - 2030, USD Million
TABLE 213 Asia Pacific Vaccinology Market, by Country, 2019 - 2022, USD Million
TABLE 214 Asia Pacific Vaccinology Market, by Country, 2023 - 2030, USD Million
TABLE 215 Asia Pacific Viral Vector Production Market, by Country, 2019 - 2022, USD Million
TABLE 216 Asia Pacific Viral Vector Production Market, by Country, 2023 - 2030, USD Million
TABLE 217 China Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 218 China Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 219 China Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 220 China Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 221 China Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 222 China Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 223 China Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 224 China Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 225 Japan Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 226 Japan Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 227 Japan Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 228 Japan Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 229 Japan Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 230 Japan Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 231 Japan Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 232 Japan Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 233 India Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 234 India Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 235 India Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 236 India Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 237 India Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 238 India Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 239 India Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 240 India Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 241 South Korea Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 242 South Korea Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 243 South Korea Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 244 South Korea Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 245 South Korea Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 246 South Korea Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 247 South Korea Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 248 South Korea Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 249 Singapore Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 250 Singapore Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 251 Singapore Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 252 Singapore Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 253 Singapore Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 254 Singapore Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 255 Singapore Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 256 Singapore Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 257 Malaysia Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 258 Malaysia Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 259 Malaysia Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 260 Malaysia Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 261 Malaysia Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 262 Malaysia Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 263 Malaysia Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 264 Malaysia Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 265 Rest of Asia Pacific Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 266 Rest of Asia Pacific Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 267 Rest of Asia Pacific Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 268 Rest of Asia Pacific Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 269 Rest of Asia Pacific Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 270 Rest of Asia Pacific Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 271 Rest of Asia Pacific Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 272 Rest of Asia Pacific Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 273 LAMEA Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 274 LAMEA Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 275 LAMEA Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 276 LAMEA Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 277 LAMEA Adeno-Associated Viral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 278 LAMEA Adeno-Associated Viral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 279 LAMEA Lentiviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 280 LAMEA Lentiviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 281 LAMEA Adenoviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 282 LAMEA Adenoviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 283 LAMEA Retroviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 284 LAMEA Retroviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 285 LAMEA Others Market, by Country, 2019 - 2022, USD Million
TABLE 286 LAMEA Others Market, by Country, 2023 - 2030, USD Million
TABLE 287 LAMEA Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 288 LAMEA Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 289 LAMEA Cancer Market, by Country, 2019 - 2022, USD Million
TABLE 290 LAMEA Cancer Market, by Country, 2023 - 2030, USD Million
TABLE 291 LAMEA Genetic Disorders Market, by Country, 2019 - 2022, USD Million
TABLE 292 LAMEA Genetic Disorders Market, by Country, 2023 - 2030, USD Million
TABLE 293 LAMEA Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 294 LAMEA Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 295 LAMEA Others Market, by Country, 2019 - 2022, USD Million
TABLE 296 LAMEA Others Market, by Country, 2023 - 2030, USD Million
TABLE 297 LAMEA Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 298 LAMEA Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 299 LAMEA Gene Therapy Market, by Country, 2019 - 2022, USD Million
TABLE 300 LAMEA Gene Therapy Market, by Country, 2023 - 2030, USD Million
TABLE 301 LAMEA Vaccinology Market, by Country, 2019 - 2022, USD Million
TABLE 302 LAMEA Vaccinology Market, by Country, 2023 - 2030, USD Million
TABLE 303 LAMEA Viral Vector Production Market, by Country, 2019 - 2022, USD Million
TABLE 304 LAMEA Viral Vector Production Market, by Country, 2023 - 2030, USD Million
TABLE 305 Brazil Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 306 Brazil Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 307 Brazil Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 308 Brazil Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 309 Brazil Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 310 Brazil Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 311 Brazil Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 312 Brazil Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 313 Argentina Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 314 Argentina Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 315 Argentina Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 316 Argentina Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 317 Argentina Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 318 Argentina Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 319 Argentina Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 320 Argentina Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 321 UAE Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 322 UAE Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 323 UAE Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 324 UAE Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 325 UAE Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 326 UAE Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 327 UAE Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 328 UAE Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 329 Saudi Arabia Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 330 Saudi Arabia Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 331 Saudi Arabia Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 332 Saudi Arabia Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 333 Saudi Arabia Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 334 Saudi Arabia Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 335 Saudi Arabia Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 336 Saudi Arabia Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 337 South Africa Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 338 South Africa Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 339 South Africa Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 340 South Africa Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 341 South Africa Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 342 South Africa Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 343 South Africa Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 344 South Africa Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 345 Nigeria Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 346 Nigeria Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 347 Nigeria Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 348 Nigeria Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 349 Nigeria Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 350 Nigeria Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 351 Nigeria Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 352 Nigeria Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 353 Rest of LAMEA Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 354 Rest of LAMEA Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 355 Rest of LAMEA Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 356 Rest of LAMEA Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 357 Rest of LAMEA Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 358 Rest of LAMEA Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 359 Rest of LAMEA Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 360 Rest of LAMEA Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 361 Key Information - Andelyn Biosciences, Inc.
TABLE 362 key information - Charles River Laboratories International, Inc.
TABLE 363 Key Information - Danaher Corporation
TABLE 364 Key Information - FinVector Oy
TABLE 365 Key Information - Thermo Fisher Scientific, Inc.
TABLE 366 Key Information - Novartis AG
TABLE 367 Key Information - Takara Bio Inc.
TABLE 368 Key Information - Avid Bioservices, Inc.
TABLE 369 Key Information - Oxford Biomedica PLC
TABLE 370 Key Information -Lonza Group Ltd.

Global Viral Vector Production Market Size, Share & Trends Analysis Report By Type, By Indication, By Application, By Regional Outlook and Forecast, 2023 - 2030

Description

Table of Contents